Rapamycin (sirolimus, rapamune)
- 1 November 1995
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 4 (6) , 482-487
- https://doi.org/10.1097/00041552-199511000-00004
Abstract
Rapamycin is a novel immunosuppressive agent that is undergoing clinical trials for use in allograft rejection therapy. This paper reviews its in-vitro biological properties, the current state of knowledge concerning its mechanism of action, and its therapeutic applications.Keywords
This publication has 0 references indexed in Scilit: